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ABSTRACT: Single-module nonribosomal peptide synthe-
tases (NRPSs) and NRPS-like enzymes activate and trans-
form carboxylic acids in both primary and secondary metab-
olism; and are of great interests due to their biocatalytic po-
tentials. The single-module NRPS IvoA is essential for fungal 
pigment biosynthesis. Here, we show that IvoA catalyzes 
ATP-dependent unidirectional stereoinversion of L-trypto-
phan to D-tryptophan with complete conversion.  While the 
stereoinversion is catalyzed by the epimerization (E) domain, 
the terminal condensation (C) domain stereoselectively hy-
drolyzes D-tryptophanyl-S-phosphopantetheine thioester and 
thus represents a noncanonical C domain function. Using 
IvoA, we demonstrate a biocatalytic stereoinversion/derace-
mization route to access a variety of substituted D-tryptophan 
analogs in high enantiomeric excess. 
Nonribosomal peptide synthetases (NRPSs) are modu-
lar enzymes employing an assembly-line logic to synthesize 
a myriad of peptide-based secondary metabolites with di-
verse structures and biological activities.1 Single-module 
NRPS and NRPS-like enzymes adopt similar thiotemplated 
enzymology with a single set of adenylation (A) and thiolation 
(T) domain. These enzymes have important functions in 
transforming carboxylic acid substrates in primary and sec-
ondary metabolism;2 and have increased interests as biocat-
alysts due to their functional diversity (Figure 1).3 Following 
selection and thermodynamic activation of the carboxylic acid 
by the A domain,  the substrate is preserved as phosphopan-
tetheine (Ppant) thioester on the T domain. Depending on the 
type of downstream releasing domains, the thioester inter-
mediates are subjected to a broad range of modifications 
(Figure 1a), including but not limited to: esterification/ami-
dation by a condensation (C) domain in A-T-C;4 Dieckman/al-
dol condensation or cyclization by a thioesterase (TE) do-
main in A-T-TE;5,6 2- or 4-electron reduction by reductase (R) 
domain in either A-T-R or A-T-R-R;2b,7 2-electron reduction 
followed by PLP-dependent aldol condensation in A-T-R-P.8 
In natural product biosynthetic pathways, these enzymes 
generate natural product scaffolds with structural diversity 
that complements the chemical space of canonical nonribo-
somal peptides, such as dihydroxybenzoquinone, furanone, 
butyrolactone, and dihydropyrazine (Figure 1A).  
Recently, a single-module NRPS, encoded by the gene 
ivoA from Aspergillus nidulans with an unusual domain archi-
tecture annotated as A-T-C-C* was proposed to acetylate L-
tryptophan.9 The enzymatic product N-acetyl-L-tryptophan 
was suggested to be further oxidized by a P450 enzyme IvoC 
and a phenol oxidase IvoB en route to the conidiophore pig-
ment (Figure 1B). Although genetic studies provided com-
pelling evidence implicating ivoA in the biosynthesis of N-ac-
etyl-hydroxytryptophan,10,11 the proposed acetyltransferase 
activity of IvoA is an unlikely fit for a single-module NRPS. 
Furthermore, the mechanistic proposal for IvoA is at odds 
with accepted logic of NRPS enzymology for the following 
reasons:1) It is metabolically wasteful to activate the carboxy 
group of a substrate at the expense of one equivalent of ATP 
in order to accomplish N-acetylation by acetyl-CoA; 2) It is 
against the NRPS directionality rule for a downstream C do-
main to carry out a condensation reaction (acetylation here) 
with an upstream T domain as the acceptor.1,12  
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Figure 1.  Diverse functions of single-module NRPS and 
NRPS-like enzymes. A) Characterized examples. B) IvoA 
studied in this work.  
To elucidate the enzymatic function of IvoA, we first re-
analyzed its domain architecture. Since epimerization (E) do-
mains show sequence and structure homology to C domains, 
and are often inserted between T and C domains in the 
NRPS assembly lines,12 we hypothesized that the true do-
main organization of IvoA is A-T-E-C. Embedding a func-
tional E domain could rationalize the necessity of involving 
NRPS machinery: activation of the -carboxy group can 
lower the pKa of the Cproton, thereby facilitating stereoin-
version. To test this hypothesis, we overexpressed IvoA by 
using S. cerevisiae JHY686 strain as a heterologous host.13 
Consistent with the previous report, we were able to detect 
N-acetyltryptophan formation. However, the purified product 
from yeast cell culture was found to be exclusively D-enanti-
omeric (ee > 99%) as confirmed by chiral-HPLC analysis 
(Figure 2A). The inverted stereochemistry of tryptophan sup-
ports our hypothesis that an E domain is present within IvoA.   
 
Figure 2. Characterization of IvoA activity. A) Stereochem-
istry determination for isolated N-acetyl-D-tryptophan. B) 
Mass spectrometry shows the mass shift of tryptophan 
when the assay was performed in D2O. C) 1H-NMR spectra 
indicate incorporation of deuterium at the  position: 1) the 
change of splitting pattern of the diastereotopic  proton sig-
nal due to smaller coupling constant (3JH-D)); 2) the disap-
pearance of  proton signal. D) Chiral HPLC resolution of 
tryptophan enantiomers from IvoA reaction demonstrated 
complete stereoinversion of L-tryptophan to D-tryptophan. 
To interrogate the function of IvoA, particularly the cryp-
tic acetyltransferase activity, we purified IvoA from S. cere-
visiae and assayed its activity in vitro (Figure S1). We first 
examined the substrate specificity of IvoA adenylation do-
main (Figure S2). As expected, L-tryptophan is the preferred 
substrate, while D-tryptophan is activated with 64% lower ef-
ficiency (Figure S2). We were unable to detect formation of 
acetylated tryptophan starting from either L/D-tryptophan in 
the presence of ATP, provided with either acetyl-CoA or ac-
etyl-phosphate as the acetyl-donor. Increasing enzyme con-
centration to > 50 µM, plus prolonged overnight incubation 
only led to trace amount of N-acetyl-D-tryptophan (kobsapp < 
0.1 h-1, Figure S3).  
When we performed the assay ([E] = 2 µM) in D2O and 
analyzed the reaction mixture by LC-MS, we readily ob-
served a gradual +1 Da mass shift of tryptophan (Figure 2B). 
This deuterium “wash-in” result is phosphopantetheinylation-
dependent as inactivating the T domain (IvoA-T0, S785A mu-
tation) completely abolished the incorporation. Monitoring the 
reaction by 1H-NMR confirmed that the hydrogen-deuterium 
exchange took place at the C (Figure 2C), indicating that 
epimerization of tryptophanyl-S-Ppant occurred. The com-
plete hydrogen-deuterium exchange is also consistent with 
the “two-base” mechanism proposed for NRPS E domain.14  
Table 1. Apparent steady-state kinetic constants of L-
tryptophan stereoinversion by IvoA and mutants. 
Enzyme kcatapp  (min-
1) 
 Kmapp  (µM) (kcat /Km )app  
(M-1 s-1) 
WTa 38 ± 3  50 ± 10 1.3 x 104 
T0(S785A)  inactive inactive inactive 
E0(H963A) 0.09 ± 0.03 50 ± 10 30 
 3 
C0(H1428A) 
0.008 ± 
0.002 
40 ± 10 3.5 
aSubstrate inhibition was observed with Ki app of 4 ± 1 (mM).  
We next followed the reaction by using chiral-HPLC and 
complete conversion of L-tryptophan (1 mM) to D-tryptophan 
was observed in 3 hours (Figure 2D). Chiral-resolution al-
lowed us to determine the apparent steady-state kinetics by 
quantifying D-tryptophan formation (Table 1, Figure S4). The 
apparent kcat (38 min-1) is similar to that of other character-
ized single-module NRPSs and NRPS-like enzymes,4,7 while 
the Km (~50 µM) is close to the intracellular level of L-trypto-
phan (12 µM).15 Both E and C domains are catalytically im-
portant for IvoA, as inactivating either domain by mutating the 
catalytic histidine residues (H963A and H1428A) substan-
tially compromised the apparent turnover number kcat (420-
fold by E0 while 4700-fold by C0). In contrast, the apparent 
Michaelis constants were not changed, suggesting that sub-
strate binding (at the A domain) was not affected. 
Taken together, these data indicate that IvoA lacks 
acetyltransferase activity in vitro, but instead is a bona fide 
ATP-dependent enzyme catalyzing enantioselective stere-
oinversion of L-tryptophan to D-tryptophan. The observed 
acetylation of D-tryptophan in vivo must be carried out by an 
endogenous acetyltransferase. Because yeast histone 
acetyltransferase Hpa3 is known to act as a D-amino acid N-
acetyltransferase for detoxification of D-amino acids,16 we 
overexpressed IvoA in the hpa3-deleted yeast strain con-
structed by replacing hpa3 with leu2 (SI Methods, Figure S5). 
Consequently, the culture medium was devoid of N-
acetyltryptophan, whereas free D-tryptophan (ee = 98%) 
were still accumulated inside the cells (Figure S6-S7). 
Therefore, we conclude that IvoA does not acetylate trypto-
phan and the origin of the negligible acetyltransferase activity 
of IvoA observed in vitro may derive from trace amount of 
contaminated yeast Hpa3. 
Scheme 1. Stereoinversion of amino acid enantiomer 
into its mirror-image counterpart by common racemases 
and IvoA.  
 
Distinct from common PLP-dependent or PLP-
independent amino acid racemases (Scheme 1), which often 
catalyze bidirectional stereoinversion and also inevitably lead 
to racemization (equilibrium constant approaches unity),17 
IvoA catalyzes unidirectional stereoinversion, completely 
converting L-tryptophan to its enantiomer D-tryptophan. The 
complete conversion is driven by coupled ATP hydrolysis, 
which is thermodynamically favored (Scheme 1),18 and is en-
abled by the thiotemplate enzymology of IvoA (Figure 3). We 
reason that the activated tryptophan is delivered to the E do-
main as tryptophanyl-S-Ppant thioester, which undergoes 
epimerization to give a mixture of D/L-tryptophanyl-S-Ppant 
diastereoisomers in equilibrium. We propose that dynamic ki-
netic resolution may be accomplished by the C domain in a 
releasing step, which stereoselectively hydrolyzes the D-tryp-
tophanyl-S-Ppant thioester to achieve irreversible conver-
sion. 
 
Figure 3. Working model of IvoA.  
As mentioned earlier, even though IvoA A domain pre-
fers L-tryptophan, D-tryptophan can still be adenylated and 
thioesterified (Figure S2). In addition, the loaded D-trypto-
phanyl-S-Ppant underwent epimerization by IvoA E domain 
as evidenced by similar, yet slower deuterium “wash-in” be-
havior under multiple-turnover condition (Figure S8). The 
slower turnover measured by deuterium incorporation re-
flects the lower adenylation efficiency of D-tryptophan. None-
theless, the occurrence of hydrogen-deuterium exchange at 
D-tryptophanyl-S-Ppant C position not only suggests that 
epimerization is faster than the C-domain catalyzed D-spe-
cific tryptophanyl thioester hydrolysis, but also indicates that 
the D/L-tryptophanyl-S-Ppant equilibrium can be approached 
from either direction (Figure 3). However, IvoA cannot con-
vert D-tryptophan to L-tryptophan, which suggests that the L-
tryptophanyl-S-Ppant is not hydrolyzed by the C domain. A 
D-specific hydrolytic releasing C domain is therefore the key 
for unidirectional complete stereoinversion. 
To directly demonstrate the stereoselectivity of IvoA C 
domain, we purified the standalone IvoA-C and assayed its 
activity in vitro. Addition of IvoA-C in equimolar to either 
IvoA(C0) mutant or IvoA-C truncation mutant successfully 
rescued the impaired stereoinversion activity, which proved 
that the standalone IvoA-C is active (Figure S9). We then 
synthesized both D- and L-tryptophanyl-S-N-acetylcysteam-
ine as surrogate substrates mimicking the IvoA T domain 
bound tryptophanyl-S-Ppant intermediates. However, the en-
zyme did not catalyze hydrolysis significantly above the back-
ground nonenzymatic rate (Figure S10). Using D-tryptopha-
nyl-S-pantetheine (D-Trp-pant) also did not improve enzy-
matic hydrolysis. We reason that the protein:protein interac-
tion between T and C domain is important for substrate 
recognition, which has been shown in other studies of C do-
mains.19 Hence, we chose to enzymatically load D/L-trypto-
phan to IvoA-C(E0) by taking advantage of the promiscuous 
A domain. It is imperative to inactivate the E domain in this 
truncation mutant in order to minimize the epimerization. The 
formation of corresponding D/L-tryptophanyl-S-Ppant of IvoA-
C was confirmed by intact protein mass spectrometry (Fig-
ure S11). Free excess D/L-tryptophan substrates were 
quickly removed from IvoA-C(E0) by using desalting spin 
columns and the loaded D/L-tryptophanyl-S-IvoA-C(E0) were 
immediately subjected to IvoA-C catalyzed hydrolysis. The 
liberated free tryptophan was then quantified by LC-MS. As 
shown in Figure 4, IvoA-C stereoselectively hydrolyzed D-
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tryptophanyl-S-IvoA-C(E0) over L-tryptophanyl-S-IvoA-
C(E0). NRPS C domains that have thioesterase activity are 
rare, and to date only one example from crocacin PKS-NRPS 
hybrid assembly-line was known, but did not show stereose-
lectivity.20 Therefore, the IvoA-C characterized here repre-
sents a novel C domain and we classify it as a DCH2O subtype 
according to the universally acknowledged nomenclature.12   
 
Figure 4. Characterization of IvoA-C activity in vitro by LC-
MS.  
The verified stereoinversion activity of IvoA prompted us to 
explore its biocatalytic potential. D-tryptophan and its substi-
tuted analogues are important building blocks for many pep-
tide pharmaceuticals, such as FDA approved lanreotide, 
pasireotide, octreotide, macimorelin, triptorelin, etc. Re-
cently, there is growing interest in developing biocatalytic 
processes for syntheses of substituted D-tryptophans by ste-
reoinversion and deracemization from the L-enantiomers and 
rac-tryptophans, respectively.21 However, to overcome the 
entropically unfavorable deracemization process (G o = 0.4 
kcal/mol),22 the current methods are  based on multi-step 
cascade reactions to establish non-equilibrium conditions for 
enrichment of D-enantiomers.21 In contrast, IvoA offers a con-
cise one-step, direct nonredox stereoinversion/deracemiza-
tion process, and allows us to access a library of D-trypto-
phan analogues in high enantiomeric excess (ee >99%) at 
millimolar level. Different substitution groups, either electron-
withdrawing or electron-donating, at most positions (4, 5, 6 
and 7) on the indole ring can be tolerated (Table 2). No con-
version of 2-Me-DL-tryptophan is due to inefficient activation 
by A domain (Figure S12), which suggests that substitution 
at 2-position may interfere with substrate recognition. The 
poor substrates are generally those with larger substituents 
(e.g. 5-NO2, 5-CN, 6-Br, 7-Br), which reflects the size limit by 
IvoA A domain. In light of recent success in A domain engi-
neering,23 it is conceivable that the substrate scope can be 
expanded in the future by enlarging the substrate binding 
pocket of A domain.   
In summary, our biochemical study uncovered the unusual 
activity of IvoA, and our findings expand the function diversity 
of single-module NRPSs. The reassigned function of IvoA 
also provides insight to fungal pigment biosynthesis. By in-
verting the chirality of tryptophan, IvoA perhaps can modulate 
amino acid flux to pigment biosynthesis in vivo. Considering 
the proposed role of IvoB and IvoC, one can speculate that 
the D-configuration generated by IvoA may be retained in the 
final uncharacterized conidiophore pigment.  
Table 2. Biocatalytic stereoinversion or deracemization 
of substituted tryptophans.a 
 
Entry Substrate ee (%) 
Stereochemis-
try 
R 
1 L H >99 
2 L 5-OMe >99 
3 rac 5-CN 63 
4 rac 5-NO2 44 
5 rac 4-F >99 
6 rac 5-F >99 
7 rac 6-F >99 
8 rac 5-Cl >99 
9 rac 6-Cl 98 
10 rac 5-Br >99 
11 rac 6-Br 75 
12 rac 7-Br 87 
13 rac 2-Me 1.3 
14 rac 4-Me >99 
15 rac 5-Me >99 
16 rac 6-Me 97 
17 rac 7-Me >99 
aExpt. Cond.: 1.5 mM substrates, 5 µM IvoA, 5 mM ATP, 10 mM 
MgCl2, 100 mM K2HPO4 buffer, pH 7.5.  
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